Literature DB >> 25423344

Prognostic value of SUVmean in oropharyngeal and hypopharyngeal cancers: comparison with SUVmax and other volumetric parameters of 18F-FDG PET.

Kyoungjune Pak1, Gi Jeong Cheon, Keon Wook Kang, June-Key Chung, E Edmund Kim, Dong Soo Lee.   

Abstract

PURPOSE: We investigated whether SUV parameters, from PET, can provide prognostic information for patients with oropharyngeal or hypopharyngeal cancer. PATIENTS AND METHODS: Forty-eight patients with oropharyngeal or hypopharyngeal cancer who underwent PET before treatment were enrolled. A volume of interest was placed on PET images covering the entire tumor volume and metastatic lymph nodes, and the SUVmax, SUVmean, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured.
RESULTS: With the use of Kaplan-Meier analysis, age, SUVmean, MTV, and TLG predicted decreased disease-free survival (DFS). However, SUVmax was not associated with DFS. In multivariate analysis, the variables were included in 3 separate models. An SUVmean2.5 was an independent prognostic factor for DFS. Other SUV parameters, such as MTV and TLG, were associated with trends toward a decreasing DFS.
CONCLUSIONS: SUVmean of PET was an independent prognostic factor for DFS in patients with oropharyngeal and hypopharyngeal cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25423344     DOI: 10.1097/RLU.0000000000000613

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  6 in total

1.  Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.

Authors:  Peter Lin; Myo Min; Mark Lee; Lois Holloway; Dion Forstner; Victoria Bray; Allan Fowler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-21       Impact factor: 9.236

2.  Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.

Authors:  Xiaokai Mo; Xiangjun Wu; Di Dong; Baoliang Guo; Changhong Liang; Xiaoning Luo; Bin Zhang; Lu Zhang; Yuhao Dong; Zhouyang Lian; Jing Liu; Shufang Pei; Wenhui Huang; Fusheng Ouyang; Jie Tian; Shuixing Zhang
Journal:  Eur Radiol       Date:  2019-10-30       Impact factor: 5.315

3.  Utility and limitations of metabolic parameters in head and neck cancer: finding a practical segmentation method.

Authors:  Jefferson Rijo-Cedeño; Jorge Mucientes; Ithzel María Villarreal; Ana Royuela; Patricia García Vicente; José Ramón García-Berrocal
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-05-02       Impact factor: 3.236

4.  SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma.

Authors:  Yun Hak Kim; Dae Cheon Jeong; Kyoungjune Pak; Myoung-Eun Han; Ji-Young Kim; Liu Liangwen; Hyun Jin Kim; Tae Woo Kim; Tae Hwa Kim; Dong Woo Hyun; Sae-Ock Oh
Journal:  Oncotarget       Date:  2017-08-14

5.  Functional Parameters of 18F-FDG PET/CT in Patients with Primary Testicular Diffuse Large B-Cell Lymphoma.

Authors:  Jing Yang; Sha Zhu; Fuwen Pang; Miao Xu; Yiting Dong; Jianqi Hao; Xuelei Ma
Journal:  Contrast Media Mol Imaging       Date:  2018-09-27       Impact factor: 3.161

6.  Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and 18F-FDG uptake in laryngeal and hypopharyngeal carcinomas.

Authors:  Li-Fang Shen; Shui-Hong Zhou; Qi Yu
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.